Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dicerna Pharmaceutic (DRNA)

Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dicerna Pharmaceutic 75 HAYDEN AVENUE LEXINGTON MA 02421 USA

www.dicerna.com P: 617-621-8097 F: 617-612-6298

Description:

Dicerna Pharmaceuticals, Inc. is focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers. The company uses its proprietary RNA interference technology platform primarily in the United States and internationally. Dicerna Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 2,986,090
Shares Outstanding, K 78,129
Annual Sales, $ 164,310 K
Annual Net Income, $ -112,750 K
Last Quarter Sales, $ 62,950 K
Last Quarter Net Income, $ -17,070 K
60-Month Beta 0.80
% of Insider Shareholders 10.20%
% of Institutional Shareholders 78.91%
Float, K 70,160
% Float 89.80%

Growth:

1-Year Return 63.12%
3-Year Return 223.08%
5-Year Return 1,153.11%
5-Year Revenue Growth 91,183.33%
5-Year Earnings Growth 50.81%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -1.63
EPS Growth vs. Prev Qtr 58.49%
EPS Growth vs. Prev Year 24.14%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DRNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -103.08%
Return-on-Assets % -16.58%
Profit Margin % -68.62%
Debt/Equity 0.00
Price/Sales 18.07
Price/Cash Flow N/A
Price/Book 27.59
Book Value/Share 1.39
Interest Coverage -5,636.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar